Moderna gets $50M investment for Ebola vaccine candidate
Global health foundation Coalition for Epidemic Preparedness Innovations (CEPI) will invest $50 million to support development and initial clinical testing of Moderna’s investigational vaccine against the Bundibugyo strain of Ebola, the deadly virus ripping through parts of the D
Global health foundation Coalition for Epidemic Preparedness Innovations (CEPI) will invest $50 million to support development and initial clinical testing of Moderna’s investigational vaccine against the Bundibugyo strain of Ebola, the deadly virus ripping through parts of the Democratic Republic of Congo. If early data are positive, the funding would also support manufacturing and progression to later-stage…
This report comes from The Hill. The story centres on Moderna gets $50M investment for Ebola vaccine candidate. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from The Hill and related outlets covering this beat.
